A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...

and prevalence of levodopa-induced dyskinesias). The other peak is centered in PCC, which has previously been shown to be abnormally active in depression or anxiety. This region probably includes ...

In early, levodopa-naive PD patients, Stalevo induced more dyskinesia than similar dosages of levodopa/carbidopa, so the regimen tested (target maintenance dose Stalevo 100 four-times daily given ...

20 The most common levodopa-induced dyskinesias occur at the time of the maximal plasma levodopa concentration and clinical response ('peak-dose dyskinesia'). Any part of the body can be involved ...

University of Arizona researchers have advanced understanding of a common complication in Parkinson’s disease treatment: involuntary movements known as levodopa-induced dyskinesia. Published in Brain, ...

Not all patients develop dyskinesias with levodopa therapy. Risk factors for levodopa-induced dyskinesias include earlier age of onset of PD, longer duration of disease, longer duration of levodopa ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of ...

GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 /IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January ...